APA (7th ed.) Citation

Sreenath M. Krishnan, Sofiene S. Laarif, Brendan C. Bender, Angelica L. Quartino, & Lena E. Friberg. (2021). Tumor growth inhibition modeling of individual lesion dynamics and interorgan variability in HER2‐negative breast cancer patients treated with docetaxel. Wiley.

Chicago Style (17th ed.) Citation

Sreenath M. Krishnan, Sofiene S. Laarif, Brendan C. Bender, Angelica L. Quartino, and Lena E. Friberg. Tumor Growth Inhibition Modeling of Individual Lesion Dynamics and Interorgan Variability in HER2‐negative Breast Cancer Patients Treated with Docetaxel. Wiley, 2021.

MLA (9th ed.) Citation

Sreenath M. Krishnan, et al. Tumor Growth Inhibition Modeling of Individual Lesion Dynamics and Interorgan Variability in HER2‐negative Breast Cancer Patients Treated with Docetaxel. Wiley, 2021.